Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M C Pérault

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Therapie|February 24, 2001
[Benzodiazepines and pregnancy]M C Pérault, S Favrelière, P Minet, et al.
Annales Medico-Psychologiques|February 1, 1995
[Cytochrome p450 IID6, its role in psychopharmacology]L Lamard, M C Pérault, S Bouquet, et al.
L'Encephale|June 2, 2010
[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]S Favrelière, A Nourrisson, N Jaafari, et al.
International Journal of Sports Medicine|March 17, 2006
Urinary and blood concentrations of beta2-agonists in trained subjects: comparison between routes of useA Pichon, N Venisse, E Krupka, et al.
Therapie|February 24, 2001
[Attitude of the clinican toward adverse effects of protease inhibitors]B Nicol, X Champagne, J P Breux, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 6, 2009
Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's diseaseF Chavant, J Deguil, S Pain, et al.
Targeted Oncology|February 20, 2016
Cardiovascular risk profile of patients with peripheral arterial occlusive disease during nilotinib therapyE Bondon-Guitton, S Combret, M C Pérault-Pochat, et al.
La Revue De Medecine Interne|October 30, 2016
[Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study]E Weber, G Moulis, M Mahévas, et al.
Drug Safety|March 22, 2013
The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenzaF Chavant, I Ingrand, A P Jonville-Bera, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Therapie|February 24, 2001
[Benzodiazepines and pregnancy]M C Pérault, S Favrelière, P Minet, et al.
Annales Medico-Psychologiques|February 1, 1995
[Cytochrome p450 IID6, its role in psychopharmacology]L Lamard, M C Pérault, S Bouquet, et al.
L'Encephale|June 2, 2010
[Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn]S Favrelière, A Nourrisson, N Jaafari, et al.
International Journal of Sports Medicine|March 17, 2006
Urinary and blood concentrations of beta2-agonists in trained subjects: comparison between routes of useA Pichon, N Venisse, E Krupka, et al.
Therapie|February 24, 2001
[Attitude of the clinican toward adverse effects of protease inhibitors]B Nicol, X Champagne, J P Breux, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 6, 2009
Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's diseaseF Chavant, J Deguil, S Pain, et al.
Targeted Oncology|February 20, 2016
Cardiovascular risk profile of patients with peripheral arterial occlusive disease during nilotinib therapyE Bondon-Guitton, S Combret, M C Pérault-Pochat, et al.
La Revue De Medecine Interne|October 30, 2016
[Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study]E Weber, G Moulis, M Mahévas, et al.
Drug Safety|March 22, 2013
The PREGVAXGRIP study: a cohort study to assess foetal and neonatal consequences of in utero exposure to vaccination against A(H1N1)v2009 influenzaF Chavant, I Ingrand, A P Jonville-Bera, et al.
Pageof 1